Emery Pharma Announces New Biologics Analytical Division
ALAMEDA, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Emery Pharma has officially expanded its state-of-the-art laboratories which feature a brand-new High-Resolution Orbitrap Mass Spectrometer, enabling Emery Pharma to expand its service offerings.
- ALAMEDA, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Emery Pharma has officially expanded its state-of-the-art laboratories which feature a brand-new High-Resolution Orbitrap Mass Spectrometer, enabling Emery Pharma to expand its service offerings.
- We are excited for him to lead the new Large Molecule Analytical Division at Emery Pharma," said Dr. Neel Bose, CSO.
- Emery Pharma is a full-service contract research laboratory, specializing in supporting preclinical drug development, including analytical, bioanalytical solutions, microbiology & cell biology services, drug and impurity characterization, and general R&D and cGMP/GLP support.
- Emery Pharma is equipped to support the development of small molecule drugs, biologics, biosimilars, gene therapies, botanical drugs, and more.